A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate the Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Feb 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Feb 2022 According to a Glenmark Pharmaceuticals Ltd media release, this trial was conducted by Berkshire and Surrey Pathology Services.
09 Feb 2022 According to a Glenmark Pharmaceuticals Ltd media release, results from this trial were published in the Journal of Infection in August 2021.
08 Jul 2021 According to a SaNOtize Research and Development media release, the Company is in the process of regulatory submissions in several other countries, including India, Brazil and Mexico. These submissions follow the results of this study.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com